Linemen's rapid weight gain can lead to hardening of heart, arteries, but problems may be offset with increased aerobic training
Cardiac MR PET CT Program
Charles River Plaza, Suite 400
165 Cambridge Street
Boston, MA 0214
We are located in historic Beacon Hill, across the street from Massachusetts General Hospital. Our office is convenient to the Red Charles/MGH, Blue Bowdoin, and Green Government Center MBTA stops. Parking is available in the garage beneath our building via Cambridge St.
Explore This Research Lab
The Cardiac MR PET CT Program is a combined radiology/cardiology clinical research program at the Massachusetts General Hospital Corrigan Minehan Heart Center and Harvard Medical School. The Program is a thriving multimodality multidisciplinary hub for patient-oriented research focused on the translation and implementation of innovative advanced cardiovascular PET, MR, and CT imaging methods including imaging of coronary atherosclerosis, myocardial structure and function, inflammation, and adipose tissues. The program has an excellent publication, funding, and mentoring record.
The program is led by Dr. Udo Hoffmann (Director) and brings together a broad group of collaborators from cardiology and radiology with the following interests:
- The development and validation of imaging biomarkers of cardiovascular disease.
- The use of imaging biomarkers in clinical trials.
- The development and use of imaging technologies to improve patient care.
The program has led, and is leading, pioneer studies with coronary CTA, vascular inflammation and MR. Highlighted studies include large multicenter comparative effectiveness trials of cardiac CT in patients with acute (ROMICAT II) and stable (PROMISE) coronary syndromes, incidental coronary atherosclerosis and the effect of statins in HIV (REPRIEVE CT Sub-study), imaging in primary prevention in the Framingham Heart Study, the effect of methotrexate on vascular inflammation with PET in HIV (CIRT PET sub-study) and statins, myocardial fibrosis and function after anthracyclines using MR (STOP-CA).
A key component of the Program is teaching and the Program supports an embedded T32 training program in cardiovascular imaging which provides extensive high quality mentoring for MD’s and PhD's.
Randomized controlled trials to determine the effectiveness of cardiovascular imaging on health outcomes and processes of care.
Randomized controlled trials of novel therapies among patients at increased risk of heart disease including those getting chemotherapy or living with HIV.
Multi-modal, multi-tissue imaging to derive unique insights into pathobiological mechanisms contributing to cardiovascular disease.
Including baseline exposures, genetic determinants, cardiometabolic imaging phenotyping and outcomes.
Innovations in imaging computation, including 3D visualization, computational fluid dynamics, and machine learning.
Careers & Training
T32 postdoctoral fellowship (only for US citizens or permanent residents)
- MD (typically have completed residency in Radiology or general cardiology fellowship)
Two Year Fellowship application form (PDF)
- PHD: two to three year Fellowship application form (PDF)
Postdoctoral fellowship (open to US or international MDs and PhDs)
Predoctoral Fellowship (Pre-med or medical students):
For further information please contact:
Cardiac MR PET CT Fellowship Program
Massachusetts General Hospital
165 Cambridge St, Suite 400
Boston, MA 02114
The Cardiac MR PET CT Program is a dedicated team of research faculty, fellows, and research staff.
- Patient Story
- Jun | 28 | 2019
On Dec. 20, 2018, Greenfield, Massachusetts resident and tattoo artist Ben Reigle woke up at 3:50 am and was unable to move the right side of his body.
- Press Release
- Jun | 25 | 2019
A biological pathway previously found to contribute to the impact of stress on the risk of cardiovascular disease also may underlie the increased incidence of such disease experienced by individuals with lower socioeconomic status.
- Press Release
- Mar | 6 | 2019
A team led by Massachusetts General Hospital (MGH) investigators has found that activity of an important signaling pathway increases with aging and with heart failure and that inhibiting that pathway can improve cardiac function in mouse models.
- Mar | 1 | 2019
A Massachusetts General Hospital research team has identified a nucleoprotein complex that is responsible for breaking down the arterial wall in aortic aneurysm.
- Patient Story
- Feb | 22 | 2019
Nancy McCleary, RN, and her daughter Margaret “Meg” McCleary, RN, share the same last name – and a shared career in Cardiology at the MGH.